Samuel Barker

Director at Cyclacel Pharmaceuticals

Capital raised by Cyclacel Pharmaceuticals

$1.0M+$1.0M latest round

3 Form D filings · first filed Feb 2025 · Berkeley Heights, NJ

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

Cyclacel PharmaceuticalsBiotech · Berkeley Heights, NJsince Feb 2025

Director

Listed on Cyclacel Pharmaceuticals's Form D filings

Company filings

via EDGAR · Form D for Cyclacel Pharmaceuticals3

DateCompanyFormAmountRole on filing

Mar 21, 2025Cyclacel PharmaceuticalsForm D+$1.0M—

Form DMar 21, 2025 · Cyclacel Pharmaceuticals+$1.0Mnot a signer

Feb 14, 2025Cyclacel PharmaceuticalsForm D——

Form DFeb 14, 2025 · Cyclacel Pharmaceuticals—not a signer

Feb 6, 2025Cyclacel PharmaceuticalsForm D——

Form DFeb 6, 2025 · Cyclacel Pharmaceuticals—not a signer

Overview

Last filing Mar 21, 2025

Samuel Barker is on file as Director at Cyclacel Pharmaceuticals in Berkeley Heights, NJ. Cyclacel Pharmaceuticals has 3 Form D filings on record, $1.0M raised in total.

Teammates

Cyclacel Pharmaceuticals · 3

Avraham Ben-TzviDirector Datuk Dr.Doris Wong Sing EeChief Executive OfficerSigner David LazarInterim Chief Executive OfficerSigner

Products

Cyclacel Pharmaceuticals · 1

Novel Oncology TreatmentsOncology

Cyclacel Pharmaceuticals develops a range of therapeutic candidates aimed at overcoming cancer drug resistance utilizing targeted approaches in cell cycle biology, transcriptional regulation, and mitosis biology. These innovative treatments are designed to tackle cancers that have proven challenging for conventional therapies.